JESSICA COOK: Open Payments
NPI 1063426534 · WATKINSVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$710 in 34 payments from 11 companies in 2025. Trend: 2023 $900 · 2024 $1,903 · 2025 $710
Food & beverage: $710
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $188 |
| Amgen Inc. | 2 | $160 |
| GENZYME CORPORATION | 4 | $150 |
| Novartis Pharmaceuticals Corporation | 2 | $48 |
| PFIZER INC. | 2 | $35 |
| UCB, Inc. | 1 | $31 |
| Organon LLC | 4 | $31 |
| Abbott Laboratories | 1 | $25 |
| Verrica Pharmaceuticals Inc. | 1 | $16 |
| Galderma Laboratories, L.P. | 1 | $14 |
Products named: OTEZLA, DUPIXENT, SKYRIZI, RINVOQ, CIBINQO, Bimzelx, Rhapsido, CARDIOMEMS.
Industry payments across GA — which companies pay providers there.
